Global ePharmacy

ePharmacy Comprehensive Study by Type (Skin Care, Dental, Cold and Flu, Vitamins, Weight Loss, Other), Drug Type (Prescription Drugs, Over-The-Counter (OTC) Drugs), Mode of Use (Mobile Applications, Webpage Based) Players and Region - Asia Pacific Market Outlook to 2030

ePharmacy Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About ePharmacy
Today we witness a phase transition of buying pattern of any goods, clothes, electronics, furniture, grocery, etc. With the initiation of new technology, offline shopping switches to online mode. Buying anything online is in trends. Buying drugs or medicines online is the latest trend amongst patients and consumers. With this growing trend of buying medicines online, the number of online pharmacies also increase. However, there is a lack of proper regulatory forms and balances for exercising regulatory control over e-pharmacies. There are some other aspects which also fuel the gearing up of e-pharmacies such as increased number of netizens, long term illness patients and increased chronic diseases.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


Leading key players are focusing on area expansion to improve their sells and also focusing on increasing their client base to strengthen market position and to enhance product & service offerings. Analyst at AMA Research estimates that Indian Players will contribute the maximum growth to Asia Pacific ePharmacy market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Netmeds.com (India), 1mg (India), Apollo Pharmacy (India), BestKenko (Japan), Healthkart (India), PharmEasy (India), ePharmacy.com.au (Australia), MyraMed (India), Pharmacy Online (Australia) and Metapharmacy.in (India) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Medplusmart (India), mChemist (India), Medidart.com (India) and MedsonWay (India).

Segmentation Overview
AMA Research has segmented the market of Asia Pacific ePharmacy market by Type (Skin Care, Dental, Cold and Flu, Vitamins, Weight Loss and Other) and Region.



On the basis of geography, the market of ePharmacy has been segmented into Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific). If we see Market by Drug Type, the sub-segment i.e. Prescription Drugs will boost the ePharmacy market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Mode of Use, the sub-segment i.e. Mobile Applications will boost the ePharmacy market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Increasing Demand for Healthcare Products & Services

Market Growth Drivers:
Increase in the Number of Internet Consumers, Improved Access to Web-based and Online Services and Growing Implementation of E-prescriptions in Hospitals and Other Healthcare Services

Challenges:
Regulatory Hurdles Related to ePharmacy and Lack of Cold Chain Logistic Services

Restraints:
Rising Number of Illegal Online Pharmacies

Opportunities:
Rising Number of Illegal Online Pharmacies

Market Leaders and their expansionary development strategies
In September 2022, Walmart Canada and Canada Health Infoway entered a partnership. Infoway's PrescribeIT electronic prescribing service is now accessible in 14 Walmart Canada pharmacies in Ontario, Alberta, Saskatchewan, and New Brunswick, with plans to expand to additional locations by year's end.
In September 2022, Amazon stated that it was planning to sell prescription medications online in Japan. To build a platform where patients can get online instructions on taking medications, it aims to collaborate with small and medium-sized pharmacies. Without visiting a pharmacy, customers could have their drugs delivered to their homes.
The Central Drugs Standard Control Organisation (CDSCO), which regulates pharmaceuticals and medical devices in India, and the Ministry of Health and Family Welfare are currently working towards framing a policy for regulating online pharmacies.

Key Target Audience
ePharmacy Companies, Suppliers of Drugs, Online Service Providers, Healthcare Industry, Governmental Bodies, Regulatory Bodies and Research Firms

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Skin Care
  • Dental
  • Cold and Flu
  • Vitamins
  • Weight Loss
  • Other
By Drug Type
  • Prescription Drugs
  • Over-The-Counter (OTC) Drugs

By Mode of Use
  • Mobile Applications
  • Webpage Based

By Regions
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in the Number of Internet Consumers
      • 3.2.2. Improved Access to Web-based and Online Services
      • 3.2.3. Growing Implementation of E-prescriptions in Hospitals and Other Healthcare Services
    • 3.3. Market Challenges
      • 3.3.1. Regulatory Hurdles Related to ePharmacy
      • 3.3.2. Lack of Cold Chain Logistic Services
    • 3.4. Market Trends
      • 3.4.1. Increasing Demand for Healthcare Products & Services
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Asia Pacific ePharmacy, by Type, Drug Type, Mode of Use and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Asia Pacific ePharmacy (Value)
      • 5.2.1. Asia Pacific ePharmacy by: Type (Value)
        • 5.2.1.1. Skin Care
        • 5.2.1.2. Dental
        • 5.2.1.3. Cold and Flu
        • 5.2.1.4. Vitamins
        • 5.2.1.5. Weight Loss
        • 5.2.1.6. Other
      • 5.2.2. Asia Pacific ePharmacy by: Drug Type (Value)
        • 5.2.2.1. Prescription Drugs
        • 5.2.2.2. Over-The-Counter (OTC) Drugs
      • 5.2.3. Asia Pacific ePharmacy by: Mode of Use (Value)
        • 5.2.3.1. Mobile Applications
        • 5.2.3.2. Webpage Based
      • 5.2.4. Asia Pacific ePharmacy Region
        • 5.2.4.1. Asia Pacific
          • 5.2.4.1.1. China
          • 5.2.4.1.2. Japan
          • 5.2.4.1.3. India
          • 5.2.4.1.4. South Korea
          • 5.2.4.1.5. Taiwan
          • 5.2.4.1.6. Australia
          • 5.2.4.1.7. Rest of Asia-Pacific
    • 5.3. Asia Pacific ePharmacy (Price)
      • 5.3.1. Asia Pacific ePharmacy by: Type (Price)
  • 6. ePharmacy: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Netmeds.com (India)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. 1mg (India)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Apollo Pharmacy (India)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. BestKenko (Japan)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Healthkart (India)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. PharmEasy (India)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. EPharmacy.com.au (Australia)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. MyraMed (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Pharmacy Online (Australia)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Metapharmacy.in (India)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Asia Pacific ePharmacy Sale, by Type, Drug Type, Mode of Use and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Asia Pacific ePharmacy (Value)
      • 7.2.1. Asia Pacific ePharmacy by: Type (Value)
        • 7.2.1.1. Skin Care
        • 7.2.1.2. Dental
        • 7.2.1.3. Cold and Flu
        • 7.2.1.4. Vitamins
        • 7.2.1.5. Weight Loss
        • 7.2.1.6. Other
      • 7.2.2. Asia Pacific ePharmacy by: Drug Type (Value)
        • 7.2.2.1. Prescription Drugs
        • 7.2.2.2. Over-The-Counter (OTC) Drugs
      • 7.2.3. Asia Pacific ePharmacy by: Mode of Use (Value)
        • 7.2.3.1. Mobile Applications
        • 7.2.3.2. Webpage Based
      • 7.2.4. Asia Pacific ePharmacy Region
        • 7.2.4.1. Asia Pacific
          • 7.2.4.1.1. China
          • 7.2.4.1.2. Japan
          • 7.2.4.1.3. India
          • 7.2.4.1.4. South Korea
          • 7.2.4.1.5. Taiwan
          • 7.2.4.1.6. Australia
          • 7.2.4.1.7. Rest of Asia-Pacific
    • 7.3. Asia Pacific ePharmacy (Price)
      • 7.3.1. Asia Pacific ePharmacy by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. ePharmacy: by Type(USD Million)
  • Table 2. ePharmacy Skin Care , by Region USD Million (2018-2023)
  • Table 3. ePharmacy Dental , by Region USD Million (2018-2023)
  • Table 4. ePharmacy Cold and Flu , by Region USD Million (2018-2023)
  • Table 5. ePharmacy Vitamins , by Region USD Million (2018-2023)
  • Table 6. ePharmacy Weight Loss , by Region USD Million (2018-2023)
  • Table 7. ePharmacy Other , by Region USD Million (2018-2023)
  • Table 8. ePharmacy: by Drug Type(USD Million)
  • Table 9. ePharmacy Prescription Drugs , by Region USD Million (2018-2023)
  • Table 10. ePharmacy Over-The-Counter (OTC) Drugs , by Region USD Million (2018-2023)
  • Table 11. ePharmacy: by Mode of Use(USD Million)
  • Table 12. ePharmacy Mobile Applications , by Region USD Million (2018-2023)
  • Table 13. ePharmacy Webpage Based , by Region USD Million (2018-2023)
  • Table 14. Asia Pacific ePharmacy, by Country USD Million (2018-2023)
  • Table 15. Asia Pacific ePharmacy, by Type USD Million (2018-2023)
  • Table 16. Asia Pacific ePharmacy, by Drug Type USD Million (2018-2023)
  • Table 17. Asia Pacific ePharmacy, by Mode of Use USD Million (2018-2023)
  • Table 18. China ePharmacy, by Type USD Million (2018-2023)
  • Table 19. China ePharmacy, by Drug Type USD Million (2018-2023)
  • Table 20. China ePharmacy, by Mode of Use USD Million (2018-2023)
  • Table 21. Japan ePharmacy, by Type USD Million (2018-2023)
  • Table 22. Japan ePharmacy, by Drug Type USD Million (2018-2023)
  • Table 23. Japan ePharmacy, by Mode of Use USD Million (2018-2023)
  • Table 24. India ePharmacy, by Type USD Million (2018-2023)
  • Table 25. India ePharmacy, by Drug Type USD Million (2018-2023)
  • Table 26. India ePharmacy, by Mode of Use USD Million (2018-2023)
  • Table 27. South Korea ePharmacy, by Type USD Million (2018-2023)
  • Table 28. South Korea ePharmacy, by Drug Type USD Million (2018-2023)
  • Table 29. South Korea ePharmacy, by Mode of Use USD Million (2018-2023)
  • Table 30. Taiwan ePharmacy, by Type USD Million (2018-2023)
  • Table 31. Taiwan ePharmacy, by Drug Type USD Million (2018-2023)
  • Table 32. Taiwan ePharmacy, by Mode of Use USD Million (2018-2023)
  • Table 33. Australia ePharmacy, by Type USD Million (2018-2023)
  • Table 34. Australia ePharmacy, by Drug Type USD Million (2018-2023)
  • Table 35. Australia ePharmacy, by Mode of Use USD Million (2018-2023)
  • Table 36. Rest of Asia-Pacific ePharmacy, by Type USD Million (2018-2023)
  • Table 37. Rest of Asia-Pacific ePharmacy, by Drug Type USD Million (2018-2023)
  • Table 38. Rest of Asia-Pacific ePharmacy, by Mode of Use USD Million (2018-2023)
  • Table 39. ePharmacy: by Type(USD/Units)
  • Table 40. Company Basic Information, Sales Area and Its Competitors
  • Table 41. Company Basic Information, Sales Area and Its Competitors
  • Table 42. Company Basic Information, Sales Area and Its Competitors
  • Table 43. Company Basic Information, Sales Area and Its Competitors
  • Table 44. Company Basic Information, Sales Area and Its Competitors
  • Table 45. Company Basic Information, Sales Area and Its Competitors
  • Table 46. Company Basic Information, Sales Area and Its Competitors
  • Table 47. Company Basic Information, Sales Area and Its Competitors
  • Table 48. Company Basic Information, Sales Area and Its Competitors
  • Table 49. Company Basic Information, Sales Area and Its Competitors
  • Table 50. ePharmacy: by Type(USD Million)
  • Table 51. ePharmacy Skin Care , by Region USD Million (2025-2030)
  • Table 52. ePharmacy Dental , by Region USD Million (2025-2030)
  • Table 53. ePharmacy Cold and Flu , by Region USD Million (2025-2030)
  • Table 54. ePharmacy Vitamins , by Region USD Million (2025-2030)
  • Table 55. ePharmacy Weight Loss , by Region USD Million (2025-2030)
  • Table 56. ePharmacy Other , by Region USD Million (2025-2030)
  • Table 57. ePharmacy: by Drug Type(USD Million)
  • Table 58. ePharmacy Prescription Drugs , by Region USD Million (2025-2030)
  • Table 59. ePharmacy Over-The-Counter (OTC) Drugs , by Region USD Million (2025-2030)
  • Table 60. ePharmacy: by Mode of Use(USD Million)
  • Table 61. ePharmacy Mobile Applications , by Region USD Million (2025-2030)
  • Table 62. ePharmacy Webpage Based , by Region USD Million (2025-2030)
  • Table 63. Asia Pacific ePharmacy, by Country USD Million (2025-2030)
  • Table 64. Asia Pacific ePharmacy, by Type USD Million (2025-2030)
  • Table 65. Asia Pacific ePharmacy, by Drug Type USD Million (2025-2030)
  • Table 66. Asia Pacific ePharmacy, by Mode of Use USD Million (2025-2030)
  • Table 67. China ePharmacy, by Type USD Million (2025-2030)
  • Table 68. China ePharmacy, by Drug Type USD Million (2025-2030)
  • Table 69. China ePharmacy, by Mode of Use USD Million (2025-2030)
  • Table 70. Japan ePharmacy, by Type USD Million (2025-2030)
  • Table 71. Japan ePharmacy, by Drug Type USD Million (2025-2030)
  • Table 72. Japan ePharmacy, by Mode of Use USD Million (2025-2030)
  • Table 73. India ePharmacy, by Type USD Million (2025-2030)
  • Table 74. India ePharmacy, by Drug Type USD Million (2025-2030)
  • Table 75. India ePharmacy, by Mode of Use USD Million (2025-2030)
  • Table 76. South Korea ePharmacy, by Type USD Million (2025-2030)
  • Table 77. South Korea ePharmacy, by Drug Type USD Million (2025-2030)
  • Table 78. South Korea ePharmacy, by Mode of Use USD Million (2025-2030)
  • Table 79. Taiwan ePharmacy, by Type USD Million (2025-2030)
  • Table 80. Taiwan ePharmacy, by Drug Type USD Million (2025-2030)
  • Table 81. Taiwan ePharmacy, by Mode of Use USD Million (2025-2030)
  • Table 82. Australia ePharmacy, by Type USD Million (2025-2030)
  • Table 83. Australia ePharmacy, by Drug Type USD Million (2025-2030)
  • Table 84. Australia ePharmacy, by Mode of Use USD Million (2025-2030)
  • Table 85. Rest of Asia-Pacific ePharmacy, by Type USD Million (2025-2030)
  • Table 86. Rest of Asia-Pacific ePharmacy, by Drug Type USD Million (2025-2030)
  • Table 87. Rest of Asia-Pacific ePharmacy, by Mode of Use USD Million (2025-2030)
  • Table 88. ePharmacy: by Type(USD/Units)
  • Table 89. Research Programs/Design for This Report
  • Table 90. Key Data Information from Secondary Sources
  • Table 91. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Asia Pacific ePharmacy: by Type USD Million (2018-2023)
  • Figure 5. Asia Pacific ePharmacy: by Drug Type USD Million (2018-2023)
  • Figure 6. Asia Pacific ePharmacy: by Mode of Use USD Million (2018-2023)
  • Figure 7. Asia Pacific ePharmacy Share (%), by Country
  • Figure 8. Asia Pacific ePharmacy: by Type USD/Units (2018-2023)
  • Figure 9. Asia Pacific ePharmacy share by Players 2023 (%)
  • Figure 10. Asia Pacific ePharmacy share by Players (Top 3) 2023(%)
  • Figure 11. Asia Pacific ePharmacy share by Players (Top 5) 2023(%)
  • Figure 12. BCG Matrix for key Companies
  • Figure 13. Netmeds.com (India) Revenue, Net Income and Gross profit
  • Figure 14. Netmeds.com (India) Revenue: by Geography 2023
  • Figure 15. 1mg (India) Revenue, Net Income and Gross profit
  • Figure 16. 1mg (India) Revenue: by Geography 2023
  • Figure 17. Apollo Pharmacy (India) Revenue, Net Income and Gross profit
  • Figure 18. Apollo Pharmacy (India) Revenue: by Geography 2023
  • Figure 19. BestKenko (Japan) Revenue, Net Income and Gross profit
  • Figure 20. BestKenko (Japan) Revenue: by Geography 2023
  • Figure 21. Healthkart (India) Revenue, Net Income and Gross profit
  • Figure 22. Healthkart (India) Revenue: by Geography 2023
  • Figure 23. PharmEasy (India) Revenue, Net Income and Gross profit
  • Figure 24. PharmEasy (India) Revenue: by Geography 2023
  • Figure 25. EPharmacy.com.au (Australia) Revenue, Net Income and Gross profit
  • Figure 26. EPharmacy.com.au (Australia) Revenue: by Geography 2023
  • Figure 27. MyraMed (India) Revenue, Net Income and Gross profit
  • Figure 28. MyraMed (India) Revenue: by Geography 2023
  • Figure 29. Pharmacy Online (Australia) Revenue, Net Income and Gross profit
  • Figure 30. Pharmacy Online (Australia) Revenue: by Geography 2023
  • Figure 31. Metapharmacy.in (India) Revenue, Net Income and Gross profit
  • Figure 32. Metapharmacy.in (India) Revenue: by Geography 2023
  • Figure 33. Asia Pacific ePharmacy: by Type USD Million (2025-2030)
  • Figure 34. Asia Pacific ePharmacy: by Drug Type USD Million (2025-2030)
  • Figure 35. Asia Pacific ePharmacy: by Mode of Use USD Million (2025-2030)
  • Figure 36. Asia Pacific ePharmacy Share (%), by Country
  • Figure 37. Asia Pacific ePharmacy: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Netmeds.com (India)
  • 1mg (India)
  • Apollo Pharmacy (India)
  • BestKenko (Japan)
  • Healthkart (India)
  • PharmEasy (India)
  • ePharmacy.com.au (Australia)
  • MyraMed (India)
  • Pharmacy Online (Australia)
  • Metapharmacy.in (India)
Additional players considered in the study are as follows:
Medplusmart (India) , mChemist (India) , Medidart.com (India) , MedsonWay (India)
Select User Access Type

Key Highlights of Report


Mar 2024 204 Pages 77 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global ePharmacy Quantitative research analysis
Global ePharmacy Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Netmeds.com (India), 1mg (India), Apollo Pharmacy (India), BestKenko (Japan), Healthkart (India), PharmEasy (India), ePharmacy.com.au (Australia), MyraMed (India), Pharmacy Online (Australia) and Metapharmacy.in (India) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increasing Demand for Healthcare Products & Services" is seen as one of major influencing trends for ePharmacy Market during projected period 2023-2030.
The ePharmacy market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global ePharmacy Report?

Have a Query? Click Here

Other Related Reports

Hybrid OR Comprehensive Study by Type (Operating Tables, Operating Room Lights, Surgical Imaging Displays, Intraoperative Diagnostic Devices, Operating Room Communication Systems), Application (Clini...
$ 3350
Jet Lag Therapy Comprehensive Study by Application (Business Travelers, Cabin Crew, Athletes, Seasonal Travelers, Others), End Users (Hospital Pharmacies, Retail Pharmacies, Online Sales, Drug Stores...
$ 3750
Atrial Fibrillation Surgery Comprehensive Study by Type (Ablation Surgeries (Radiofrequency Ablation, Sonar, Microwave, Cryoablation), Atrioventricular Node Ablation, Maze Procedure), Application (Mi...
$ 3650
Electric Oral Care Comprehensive Study by Type (Water Flosser/Oral Irrigators, Air Flosser), Application (Online Stores, Retail Stores), End users (Adults, Children, Geriatric Population), Distributi...
$ 3350
Blood Screening Comprehensive Study by Type (Reagents & Kits, Instruments, Software & Services), Application (Blood Bank, Hospitals), Technology (Nucleic Acid Amplification Test (NAT), ELISA, Chemilu...
$ 3650
Tuberculosis Testing Comprehensive Study by Type (TB skin test (TST), TB blood tests, Others), Application (Hospitals, Clinics, Others), Disease (Active Tuberculosis, Latent Tuberculosis) Players and...
$ 3500